Search Results

• • 14 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Everolimus-based therapy in patients with hormone receptor-positive, HER2.sup.- advanced breast cancer: management considerations

  Authors:Lucia Del Mastro, Marina Cazzaniga, Paolo Solidoro, Daniele Generali, Giulia Bianchi, Franco Testore, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,209 words Report 1660LAuthor(s): Lucia Del Mastro aff1 , Marina Cazzaniga aff2 , Paolo Solidoro aff3 , Daniele Generali aff4 , Giulia Bianchi aff5 , Franco Testore aff6 , Sabino De Placido [*] aff7 KEYWORDS adverse events; breast...

• miRNA-15a/16: as tumor suppressors and more

  Authors:Enyu Huang, Ronghua Liu, and Yiwei ChuFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20158,913 words Report 1640LAuthor(s): Enyu Huang aff1 , Ronghua Liu aff1 , Yiwei Chu [*] aff1 aff2 KEYWORDS angiogenesis; cancer hallmarks; cancer therapy; immune regulator; miRNA MiR-15a and miR-16, identified as a miRNA cluster at...

• Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?

  Authors:Srinath Sundararajan and Nicholas J VogelzangFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,287 words Report 1870LAuthor(s): Srinath Sundararajan [*] aff1 , Nicholas J Vogelzang aff2 KEYWORDS bladder cancer; immunotherapy; PD-1; PD-L1 Background * Bladder cancer: what do we know? Bladder cancer is the second most...

• Corrigendum

  From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 2015351 words Correction notice 1230LFollowing publication of the Research Article by Jose Muñoz-Langa, Javier De Castro, Pere Gascó, Alfredo Sanchez, Emilio Esteban, Jose Manuel Gasent, Isidoro Barneto, Joaquin Montalar, Angel Artal & Sara Vidal titled...

• The future of targeted therapies for brain metastases

  Authors:Anna S Berghoff and Matthias PreusserFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 201510,717 words Report 2040LAuthor(s): Anna S Berghoff aff1 aff2 , Matthias Preusser [*] aff1 aff2 KEYWORDS ALK translocation; anti-HER2 therapy; brain metastases; EGFR mutation; targeted therapies Brain metastases (BM) are an increasing...

• Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors

  Authors:Ilaria Moschini, Cristina Dell'Anna, Pier Luigi Losardo, Paola Bordi, Nunziata D'Abbiero, and Marcello TiseoFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20159,247 words Report 1730LAuthor(s): Ilaria Moschini aff1 , Cristina Dell'Anna aff1 , Pier Luigi Losardo aff1 , Paola Bordi aff2 , Nunziata D'Abbiero aff1 , Marcello Tiseo [*] aff2 KEYWORDS brain radiotherapy; EGFR ; non-small-cell lung...

• Treating operable patients with gastric cancer: Macdonald's protocol versus adjuvant chemotherapy

  Authors:Pedro Nazareth Aguiar, Hakaru Tadokoro, Nora Manoukian Forones, and Ramon Andrade de MelloFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,218 words Report 1940LAuthor(s): Pedro Nazareth Aguiar aff1 , Hakaru Tadokoro aff1 , Nora Manoukian Forones aff1 , Ramon Andrade de Mello [*] aff2 aff3 KEYWORDS adjunct chemotherapy; gastric cancer; Macdonald's protocol; operable...

• Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience

  Authors:Anna M Czarnecka, Maciej Kawecki, Fei Lian, Jan Korniluk, and Cezary SzczylikFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 201511,079 words Report 1810LAuthor(s): Anna M Czarnecka [*] aff1 , Maciej Kawecki aff1 , Fei Lian aff2 , Jan Korniluk aff1 , Cezary Szczylik aff1 KEYWORDS end-stage renal disease; hemodialysis; pazopanib; renal cell cancer; renal...

• Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial

  Authors:Severine Guiu, Celine Charon-Barra, Dewi Vernerey, Pierre Fumoleau, Mario Campone, Marc Spielmann, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20158,916 words Report 1800LAuthor(s): Séverine Guiu [*] aff1 , Céline Charon-Barra aff2 , Déwi Vernerey aff3 , Pierre Fumoleau aff4 , Mario Campone aff5 , Marc Spielmann aff6 , Henri Roché aff7 , Christel Mesleard aff8 , Laurent Arnould aff2 ,...

• Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond

  Authors:Gennaro Gadaleta-Caldarola, Rosa Divella, Antonio Mazzocca, Stefania Infusino, Emanuela Ferraro, Gianfranco Filippelli, et al.From:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,111 words Report 1730LAuthor(s): Gennaro Gadaleta-Caldarola [*] aff1 , Rosa Divella aff2 , Antonio Mazzocca aff3 aff4 , Stefania Infusino aff5 , Emanuela Ferraro aff6 , Gianfranco Filippelli aff5 , Antonella Daniele aff2 , Carlo Sabbà aff3 ,...

• The utility of molecular markers in pre-operative assessment of thyroid nodules

  Authors:Parisha Bhatia, Zakaria Y Abd Elmageed, Paul Friedlander, Rizwan Aslam, and Emad KandilFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,846 words Report 1750LAuthor(s): Parisha Bhatia aff1 , Zakaria Y Abd Elmageed aff1 , Paul Friedlander aff2 , Rizwan Aslam aff2 , Emad Kandil [*] aff1 aff2 KEYWORDS biological markers; cytodiagnosis; genetic markers; immunochemistry;...

• Are predictions of cancer response to targeted drugs, based on effects in unrelated tissues, the 'Black Swan' events?

  Authors:Beatrica Kurbel, Ante Zvonimir Golem, and Sven KurbelFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20155,251 words Report 1800LAuthor(s): Beatrica Kurbel aff1 , Ante Zvonimir Golem aff2 , Sven Kurbel [*] aff3 KEYWORDS adverse effects; antineoplastic drugs; prediction markers; targeted drugs It has been well recognized that precise...

• Can cardio-oncology deliver better care internationally?

  Authors:Zaza Iakobishvili and Ran KornowskiFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,183 words Report 1690LAuthor(s): Zaza Iakobishvili [*] aff1 , Ran Kornowski aff1 KEYWORDS anthracyclines; biomarkers; brain natriuretic peptide; cancer; cardiomyopathy surveillance; cardio-oncology; cardiotoxicity; heart failure;...

• Present status and future perspectives of ALPPS (associating liver partition and portal vein ligation for staged hepatectomy)

  Authors:Marcello Donati, Francesco Basile, and Karl J OldhaferFrom:Future Oncology (Vol. 11, Issue 16) Peer-Reviewed

  Aug. 20152,273 words Report 1810LAuthor(s): Marcello Donati [*] aff1 aff2 , Francesco Basile aff1 , Karl J Oldhafer aff2 aff3 KEYWORDS ALPPS; consensus conference; extended hepatectomy; in situ split; liver hypertrophy; liver regeneration; liver...